Nurse Practitioner, Family · New York, NY
NPI
1619093721
Since 2007
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
161 Madison Ave, Suite 10e
New York, NY, 10016
Phone (646) 637-3322
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$630K
661 prescriptions
Company payments, 2024
$41.36
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Ionica E Lazar prescribed most often to Medicare patients was Auryxia (Ferric Citrate), with 142 prescriptions and refills. In total Ionica E Lazar wrote 661 Medicare prescriptions that cost $630K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-03-24.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Auryxia Ferric Citrate | 142 | 152 | 16 | $195K |
| Sevelamer Carbonate Generic | 92 | 142 | 28 | $19K |
| Velphoro Sucroferric Oxyhydroxide | 61 | 65 | Under 11 | $169K |
| Calcium Acetate Generic | 49 | 67 | Under 11 | $3,322 |
| Xphozah Tenapanor Hcl | 48 | 48 | Under 11 | $133K |
| Renvela Sevelamer Carbonate | 35 | 54 | Under 11 | $86K |
| Clinolipid Fat Emulsion/Olive/Soy/Phospho | 32 | 32 | Under 11 | $6,432 |
| Nifedipine Er Nifedipine | 24 | 44 | Under 11 | $584 |
| Prosol Parenteral Amino Acid 20% No.1 | 22 | 22 | Under 11 | $2,392 |
| Atorvastatin Calcium Generic | 19 | 35 | Under 11 | $226 |
Brand drugs: 367 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Ionica E Lazar $41.36 ($41.36 in general payments such as food, travel and fees) from 2 companies. The largest payer was Amgen Inc. with $28.25.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $28.25 |
| Fresenius USA Marketing, Inc. | 1 | $13.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.